Erdoğan Özgür
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Erdoğan Özgür has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Enis Alpin Güneri
Department of Otorhinolaryngology, School of Medicine, Dokuz Eylül University, Izmir, Türkiye
5 shared publications - Özden Savaş
Department of Otorhinolaryngology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkiye
5 shared publications - Enver Can Öncül
Department of Otorhinolaryngology – Head and Neck Surgery, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye
3 shared publications - Görkem Eskiizmir
Manisa Celal Bayar University Faculty of Medicine, Department of Otorhinolaryngology, Manisa, Türkiye
3 shared publications - Yüksel Olgun
Department of Otorhinolaryngology, Faculty of Medicine, Dokuz Eylul University, Izmir 35340, Turkey
3 shared publications - Ahmet Omer Ikiz
Department of Otorhinolaryngology, Dokuz Eylul University, Izmir 35000, Turkey
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
Incremental Value of Multimodality Imaging for Preoperative Localization in Primary Hyperparathyroidism: A Stepwise Strategy for Focused Parathyroidectomy
Incremental Value of Multimodality Imaging for Preoperative Localization in Primary Hyperparathyroidism: A Stepwise Strategy for Focused Parathyroidectomy - Turkish Archives of Otorhinolaryngology
- 29 September 2026
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
Open AccessIncremental Value of Multimodality Imaging for Preoperative Localization in Primary Hyperparathyroidism: A Stepwise Strategy for Focused Parathyroidectomy
Incremental Value of Multimodality Imaging for Preoperative Localization in Primary Hyperparathyroidism: A Stepwise Strategy for Focused Parathyroidectomy - Turkish Archives of Otorhinolaryngology
- 31 August 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (11) , 7345-7353
Predictors of difficult suspension laryngoscopy: A prospective study based on objective anthropometric measurements
- 31 August 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (11) , 7345-7353
Predictors of difficult suspension laryngoscopy: A prospective study based on objective anthropometric measurements
- Open Access
- 15 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1587
Expression of LAG-3, TIM-3, and VISTA on Tumor-Infiltrating Lymphocytes in Advanced Laryngeal Squamous Cell Carcinoma and Their Association with CD8+ TIL Density
Background: Alternative immune checkpoints such as lymphocyte-activation gene 3 (LAG-3), T-cell immunoglobulin and mucin-domain-containing-3 (TIM-3), and V-domain Ig suppressor of T-cell activation (VISTA) have emerged as potential modulators of tumor immune escape. However, their expression patterns and prognostic significance in advanced laryngeal squamous cell carcinoma (LSCC) remain insufficiently characterized. This study aimed to evaluate LAG-3, TIM-3, and VISTA expression on tumor-infiltrating lymphocytes (TILs), examine their association with CD8+ TIL density and clinicopathological features, and determine their impact on survival outcomes. Methods: In this retrospective observational cohort study, 132 patients who underwent total or partial laryngectomy for stage III–IV LSCC were included. Tissue microarrays were constructed using three 2 mm cores per case. Immunohistochemical expression of LAG-3, TIM-3, VISTA, and CD8 was assessed exclusively on TILs. Survival outcomes were analyzed using Kaplan–Meier and Cox proportional hazards models. Results: LAG-3, TIM-3, and VISTA positivity rates were 26.5%, 51.5%, and 53.8%, respectively. High CD8+ TIL density was observed in 69.7% of cases. Significant positive correlations were identified among checkpoint markers (all p < 0.05); VISTA positivity did not significantly correlate with CD8 infiltration (r = 0.149, p = 0.088). LAG-3 positivity was associated with lower thyroid cartilage invasion (p = 0.006). Kaplan–Meier analysis demonstrated no significant differences in overall survival (OS) or disease-free survival (DFS) according to checkpoint expression or CD8 status. In multivariable analysis, extranodal extension (HR = 2.719, p = 0.005) and thyroid cartilage invasion (HR = 1.970, p = 0.043) were independent predictors of worse OS. CD8 negativity showed a trend toward adverse OS (HR = 1.825, p = 0.084). None of the immune markers independently predicted DFS. Conclusions: In advanced surgically treated LSCC, LAG-3, TIM-3, and VISTA expression correlate with CD8+ TIL density but do not independently predict survival outcomes. These findings suggest that alternative immune checkpoint expression reflects immune engagement rather than intrinsic tumor aggressiveness and may hold greater predictive than prognostic relevance in LSCC.
- 15 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1587
Open AccessExpression of LAG-3, TIM-3, and VISTA on Tumor-Infiltrating Lymphocytes in Advanced Laryngeal Squamous Cell Carcinoma and Their Association with CD8+ TIL Density
Background: Alternative immune checkpoints such as lymphocyte-activation gene 3 (LAG-3), T-cell immunoglobulin and mucin-domain-containing-3 (TIM-3), and V-domain Ig suppressor of T-cell activation (VISTA) have emerged as potential modulators of tumor immune escape. However, their expression patterns and prognostic significance in advanced laryngeal squamous cell carcinoma (LSCC) remain insufficiently characterized. This study aimed to evaluate LAG-3, TIM-3, and VISTA expression on tumor-infiltrating lymphocytes (TILs), examine their association with CD8+ TIL density and clinicopathological features, and determine their impact on survival outcomes. Methods: In this retrospective observational cohort study, 132 patients who underwent total or partial laryngectomy for stage III–IV LSCC were included. Tissue microarrays were constructed using three 2 mm cores per case. Immunohistochemical expression of LAG-3, TIM-3, VISTA, and CD8 was assessed exclusively on TILs. Survival outcomes were analyzed using Kaplan–Meier and Cox proportional hazards models. Results: LAG-3, TIM-3, and VISTA positivity rates were 26.5%, 51.5%, and 53.8%, respectively. High CD8+ TIL density was observed in 69.7% of cases. Significant positive correlations were identified among checkpoint markers (all p < 0.05); VISTA positivity did not significantly correlate with CD8 infiltration (r = 0.149, p = 0.088). LAG-3 positivity was associated with lower thyroid cartilage invasion (p = 0.006). Kaplan–Meier analysis demonstrated no significant differences in overall survival (OS) or disease-free survival (DFS) according to checkpoint expression or CD8 status. In multivariable analysis, extranodal extension (HR = 2.719, p = 0.005) and thyroid cartilage invasion (HR = 1.970, p = 0.043) were independent predictors of worse OS. CD8 negativity showed a trend toward adverse OS (HR = 1.825, p = 0.084). None of the immune markers independently predicted DFS. Conclusions: In advanced surgically treated LSCC, LAG-3, TIM-3, and VISTA expression correlate with CD8+ TIL density but do not independently predict survival outcomes. These findings suggest that alternative immune checkpoint expression reflects immune engagement rather than intrinsic tumor aggressiveness and may hold greater predictive than prognostic relevance in LSCC.
- 23 April 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (8) , 5239-5245
Clinical outcomes of parathyroidectomy in primary hyperparathyroidism: a 10-year single-center experience with 115 procedures
- 23 April 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (8) , 5239-5245
Clinical outcomes of parathyroidectomy in primary hyperparathyroidism: a 10-year single-center experience with 115 procedures
- Open Access
- 29 November 2025
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Prognostic impact of Fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes
It's a well-established fact that Fusobacterium nucleatum has been implicated in the pathogenesis and prognosis of several malignancies, but its role i
- 29 November 2025
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessPrognostic impact of Fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes
It's a well-established fact that Fusobacterium nucleatum has been implicated in the pathogenesis and prognosis of several malignancies, but its role i
- Open Access
- 28 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (48) , e46190
Chronic otitis media with cholesteatoma: A retrospective observational study on the management of lateral semicircular canal fistulas
Labyrinthine fistulas are a common complication of cholesteatomatous chronic otitis media (COM), with the lateral semicircular canal (LSCC) being the most frequently affected site. This retrospective cohort study aims to evaluate the clinical management of cases with LSSC fistula secondary to cholesteatomatous COM in a tertiary care hospital and analyze the obtained results along with the literature. Between January 2009 and June 2024, patients who developed LSSC fistula due to cholesteatomatous COM and underwent surgical treatment at our center were retrospectively analyzed. The study evaluated patients’ demographic data, presenting symptoms, radiological findings, preoperative and postoperative audiological assessments, surgical approaches applied, and postoperative follow-up processes. A total of 36 patients were included in the study. Of these, 21 (58.3%) were male and 15 (41.7%) were female, with a mean age of 49.2 years. Postoperatively, patients were followed up for a minimum of 4 weeks and a maximum of 1 year. LSCC fistulas were classified based on Durko labyrinthine fistula classification, revealing Type I in 31 cases (86%), Type II in 3 cases (8%), and Type III in 2 cases (6%). Canal wall-down mastoidectomy was performed in all patients, transtemporal in 33 (92%) and inside-out mastoidectomy in 3 patients (8%). In 11 patients (31%), the fistula was covered with a temporalis muscle fascia graft, whereas in 25 patients (69%), a combination of bone dust and temporalis fascia was used for repair. No cases of recurrent cholesteatoma were detected during postoperative follow-up. The bone conduction thresholds were preserved in all patients, highlighting the positive postoperative hearing outcomes and the potential for a successful recovery. LSCC fistula is a common complication in COM with cholesteatoma patients. Early diagnosis and complete, atraumatic removal of the cholesteatoma matrix with closure using temporalis fascia and/or bone dust is a safe and effective treatment approach.
- 28 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (48) , e46190
Open AccessChronic otitis media with cholesteatoma: A retrospective observational study on the management of lateral semicircular canal fistulas
Labyrinthine fistulas are a common complication of cholesteatomatous chronic otitis media (COM), with the lateral semicircular canal (LSCC) being the most frequently affected site. This retrospective cohort study aims to evaluate the clinical management of cases with LSSC fistula secondary to cholesteatomatous COM in a tertiary care hospital and analyze the obtained results along with the literature. Between January 2009 and June 2024, patients who developed LSSC fistula due to cholesteatomatous COM and underwent surgical treatment at our center were retrospectively analyzed. The study evaluated patients’ demographic data, presenting symptoms, radiological findings, preoperative and postoperative audiological assessments, surgical approaches applied, and postoperative follow-up processes. A total of 36 patients were included in the study. Of these, 21 (58.3%) were male and 15 (41.7%) were female, with a mean age of 49.2 years. Postoperatively, patients were followed up for a minimum of 4 weeks and a maximum of 1 year. LSCC fistulas were classified based on Durko labyrinthine fistula classification, revealing Type I in 31 cases (86%), Type II in 3 cases (8%), and Type III in 2 cases (6%). Canal wall-down mastoidectomy was performed in all patients, transtemporal in 33 (92%) and inside-out mastoidectomy in 3 patients (8%). In 11 patients (31%), the fistula was covered with a temporalis muscle fascia graft, whereas in 25 patients (69%), a combination of bone dust and temporalis fascia was used for repair. No cases of recurrent cholesteatoma were detected during postoperative follow-up. The bone conduction thresholds were preserved in all patients, highlighting the positive postoperative hearing outcomes and the potential for a successful recovery. LSCC fistula is a common complication in COM with cholesteatoma patients. Early diagnosis and complete, atraumatic removal of the cholesteatoma matrix with closure using temporalis fascia and/or bone dust is a safe and effective treatment approach.
- 18 November 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Prognostic impact of fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes
INPLASY2025110054 Prognostic impact of fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes Keywords: Fusobacterium nucleatum; head and neck cancer; pr…
- 18 November 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Prognostic impact of fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes
INPLASY2025110054 Prognostic impact of fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes Keywords: Fusobacterium nucleatum; head and neck cancer; pr…
- Open Access
- 6 October 2025
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 67 (6) , 885-891
Oxytocin levels in children with childhood-onset fluency disorder
Background. Evidence suggests a role for oxytocin in language development and cognitive functions in humans. However, there is a lack of research investigating the role of oxytocin in childhood-onset fluency disorder (stuttering). The aim of this study is to compare blood oxytocin levels between children diagnosed with stuttering and healthy controls. Methods. Nineteen male children diagnosed with stuttering, aged between 6 and 11 years, and 27 typically fluent male children as a control group were included. All participants underwent psychiatric screening using the semi-structured interview The Kiddie Schedule for Affective Disorders and Schizophrenia School-Age Children-Present and Lifetime Version, and an ear, nose, throat examination. Serum oxytocin levels were determined using enzyme-linked immunosorbent assay. Results. The median (Q1-Q3) blood oxytocin levels in the case group were 113.4 (90.19-136.3) pg/mL, while in the control group were 136.7 (105.4-203.7) pg/mL. A statistically significant lower level of oxytocin was observed in the case group compared to the control group (U=162, p=0.03). Conclusions. We speculate a potential role of oxytocin in the etiology of developmental stuttering under the umbrella of neurodevelopmental disorders. The investigation of oxytocin, which plays a role in socialization and speech, in future studies on speech fluency disorders is intriguing in terms of its implications for clinical applications, including treatment.
- 6 October 2025
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 67 (6) , 885-891
Open AccessOxytocin levels in children with childhood-onset fluency disorder
Background. Evidence suggests a role for oxytocin in language development and cognitive functions in humans. However, there is a lack of research investigating the role of oxytocin in childhood-onset fluency disorder (stuttering). The aim of this study is to compare blood oxytocin levels between children diagnosed with stuttering and healthy controls. Methods. Nineteen male children diagnosed with stuttering, aged between 6 and 11 years, and 27 typically fluent male children as a control group were included. All participants underwent psychiatric screening using the semi-structured interview The Kiddie Schedule for Affective Disorders and Schizophrenia School-Age Children-Present and Lifetime Version, and an ear, nose, throat examination. Serum oxytocin levels were determined using enzyme-linked immunosorbent assay. Results. The median (Q1-Q3) blood oxytocin levels in the case group were 113.4 (90.19-136.3) pg/mL, while in the control group were 136.7 (105.4-203.7) pg/mL. A statistically significant lower level of oxytocin was observed in the case group compared to the control group (U=162, p=0.03). Conclusions. We speculate a potential role of oxytocin in the etiology of developmental stuttering under the umbrella of neurodevelopmental disorders. The investigation of oxytocin, which plays a role in socialization and speech, in future studies on speech fluency disorders is intriguing in terms of its implications for clinical applications, including treatment.
- 27 September 2025
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 198, 112575
Evaluation of the relationship between otitis media with effusion and the need for cochleostomy in pediatric cochlear implant patients
- 27 September 2025
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 198, 112575
Evaluation of the relationship between otitis media with effusion and the need for cochleostomy in pediatric cochlear implant patients